Develops a pill meant to slow Parkinson’s disease.
No change
Greenlight owns 566,130 shares of Gain Therapeutics, worth about $1 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
566,130
Jun 30
566,130
The numbers
Shares they own
566,130
Value on Jun 30, 2026
$1,149,244
about $1 million
Share of their money
0.0%
less than $1 of every $100 · 45th of 46
Price per share on Jun 30
$2.03
Kind
Shares
Also owned by
No other fund we follow
More about Gain Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.